S1PR1 and B-cell chronic lymphocytic leukemia: Figure 3a compares the effects of idelalisib and 4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[3,2d] pyrimidin -7-yl-cyclopentane (Lck-i) on S1PR1 expression on CLL cells.